---
document_datetime: 2025-12-02 06:43:48
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/yttriga.html
document_name: yttriga.html
version: success
processing_time: 0.1054987
conversion_datetime: 2025-12-28 15:02:01.207985
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Yttriga

[RSS](/en/individual-human-medicine.xml/65430)

##### Authorised

This medicine is authorised for use in the European Union

yttrium [90Y] chloride Medicine Human Authorised

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR) for Yttriga. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Yttriga.

Expand section

Collapse section

## What is Yttriga?

Yttriga is a radioactive liquid, which contains the active substance yttrium ( 90 Y) chloride. 90 Y, or yttrium-90, is a radioactive form of the chemical element yttrium.

## What is Yttriga used for?

Yttriga is not used on its own but is used for radiolabelling other medicines. Radiolabelling is a technique where a substance is labelled (tagged) with a radioactive compound. Once the substance is labelled with Yttriga, it then carries the radioactivity to where it is needed in the body, for example the site of a tumour.

Yttriga is used to label medicines that have been specially developed for use with yttrium ( 90 Y) chloride.

The medicine can only be obtained with a prescription.

## How is Yttriga used?

Yttriga is only to be used by specialists who have experience in radiolabelling. Yttriga is never given directly to a patient. Radiolabelling of a medicine takes place outside the body in a laboratory setting. The radiolabelled medicine is then given to the patient according to the instructions in that medicine's summary of product characteristics (SmPC).

## How does Yttriga work?

The active substance in Yttriga, yttrium ( 90 Y) chloride, is a radioactive compound that emits a type of radiation known as beta radiation. The effect of Yttriga depends on the nature of the medicine that is radiolabelled with it. An example of its use is the treatment of some type of tumours, where the radiolabelled medicine carries the radioactivity to the site of a tumour to destroy the tumour cells.

## How has Yttriga been studied?

As Yttriga will only be used to prepare radiolabelled medicines, no studies of Yttriga have been done in humans. The company presented information from scientific articles already published on 90 Y. The company also presented published information on the effect of using 90 Y to radiolabel other medicines, including one study of non-Hodgkin's lymphoma (a cancer of the lymph tissue, part of the immune system).

## What benefit has Yttriga shown during the studies?

The information supplied by the company shows the utility of Yttriga as a precursor to radiolabel medicines with 90 Y.

## What is the risk associated with Yttriga?

Yttriga is a precursor and will not be given on its own. The side effects seen with treatment involving Yttriga will therefore depend largely on the medicine being labelled and will be described in that medicine's package leaflet. Yttriga itself is radioactive and so its use in radiolabelling may carry a risk of cancer and hereditary defects. The doctor will ensure that the risks linked to the radioactive exposure are lower than the risks from the disease itself.

Yttriga must not be given directly to any patient. Medicines radiolabelled with Yttriga should not be used in people who may be hypersensitive (allergic) to yttrium chloride or any of the other ingredients. A medicine labelled with Yttriga must not be used in women who are or may be pregnant. More information on the restrictions on the use of medicines radiolabelled with Yttriga will be found in their package leaflets.

## Why has Yttriga been approved?

The CHMP decided that Yttriga's benefits are greater than its risks and recommended that it be given marketing authorisation.

## Other information about Yttriga

The European Commission granted a marketing authorisation valid throughout the European Union for Yttriga on 19 January 2006.

For more information about treatment with Yttriga, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Yttriga : EPAR - Summary for the public

English (EN) (116.35 KB - PDF)

**First published:** 07/08/2007

**Last updated:** 12/09/2011

[View](/en/documents/overview/yttriga-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-576)

български (BG) (153.54 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/bg/documents/overview/yttriga-epar-summary-public_bg.pdf)

español (ES) (115.76 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/es/documents/overview/yttriga-epar-summary-public_es.pdf)

čeština (CS) (143.69 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/cs/documents/overview/yttriga-epar-summary-public_cs.pdf)

dansk (DA) (117.23 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/da/documents/overview/yttriga-epar-summary-public_da.pdf)

Deutsch (DE) (119.55 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/de/documents/overview/yttriga-epar-summary-public_de.pdf)

eesti keel (ET) (116.86 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/et/documents/overview/yttriga-epar-summary-public_et.pdf)

ελληνικά (EL) (155.07 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/el/documents/overview/yttriga-epar-summary-public_el.pdf)

français (FR) (118.51 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/fr/documents/overview/yttriga-epar-summary-public_fr.pdf)

italiano (IT) (119.73 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/it/documents/overview/yttriga-epar-summary-public_it.pdf)

latviešu valoda (LV) (142.34 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/lv/documents/overview/yttriga-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (141.04 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/lt/documents/overview/yttriga-epar-summary-public_lt.pdf)

magyar (HU) (137.73 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/hu/documents/overview/yttriga-epar-summary-public_hu.pdf)

Malti (MT) (170.46 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/mt/documents/overview/yttriga-epar-summary-public_mt.pdf)

Nederlands (NL) (118.26 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/nl/documents/overview/yttriga-epar-summary-public_nl.pdf)

polski (PL) (144.49 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/pl/documents/overview/yttriga-epar-summary-public_pl.pdf)

português (PT) (118.72 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/pt/documents/overview/yttriga-epar-summary-public_pt.pdf)

română (RO) (141.04 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/ro/documents/overview/yttriga-epar-summary-public_ro.pdf)

slovenčina (SK) (141.14 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/sk/documents/overview/yttriga-epar-summary-public_sk.pdf)

slovenščina (SL) (137.85 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/sl/documents/overview/yttriga-epar-summary-public_sl.pdf)

Suomi (FI) (117.69 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/fi/documents/overview/yttriga-epar-summary-public_fi.pdf)

svenska (SV) (117.4 KB - PDF)

**First published:**

07/08/2007

**Last updated:**

12/09/2011

[View](/sv/documents/overview/yttriga-epar-summary-public_sv.pdf)

## Product information

Yttriga : EPAR - Product Information

English (EN) (319.75 KB - PDF)

**First published:** 19/08/2009

**Last updated:** 29/01/2021

[View](/en/documents/product-information/yttriga-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-876)

български (BG) (406.28 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/bg/documents/product-information/yttriga-epar-product-information_bg.pdf)

español (ES) (433.04 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/es/documents/product-information/yttriga-epar-product-information_es.pdf)

čeština (CS) (373.78 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/cs/documents/product-information/yttriga-epar-product-information_cs.pdf)

dansk (DA) (308.23 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/da/documents/product-information/yttriga-epar-product-information_da.pdf)

Deutsch (DE) (319.12 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/de/documents/product-information/yttriga-epar-product-information_de.pdf)

eesti keel (ET) (350.33 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/et/documents/product-information/yttriga-epar-product-information_et.pdf)

ελληνικά (EL) (441.73 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/el/documents/product-information/yttriga-epar-product-information_el.pdf)

français (FR) (329.48 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/fr/documents/product-information/yttriga-epar-product-information_fr.pdf)

hrvatski (HR) (370.92 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/hr/documents/product-information/yttriga-epar-product-information_hr.pdf)

íslenska (IS) (349.64 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/is/documents/product-information/yttriga-epar-product-information_is.pdf)

italiano (IT) (319.97 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/it/documents/product-information/yttriga-epar-product-information_it.pdf)

latviešu valoda (LV) (368.49 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/lv/documents/product-information/yttriga-epar-product-information_lv.pdf)

lietuvių kalba (LT) (412.93 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/lt/documents/product-information/yttriga-epar-product-information_lt.pdf)

magyar (HU) (375.28 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/hu/documents/product-information/yttriga-epar-product-information_hu.pdf)

Malti (MT) (403.73 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/mt/documents/product-information/yttriga-epar-product-information_mt.pdf)

Nederlands (NL) (354.85 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/nl/documents/product-information/yttriga-epar-product-information_nl.pdf)

norsk (NO) (282.67 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/no/documents/product-information/yttriga-epar-product-information_no.pdf)

polski (PL) (381.27 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/pl/documents/product-information/yttriga-epar-product-information_pl.pdf)

português (PT) (298.55 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/pt/documents/product-information/yttriga-epar-product-information_pt.pdf)

română (RO) (427.99 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/ro/documents/product-information/yttriga-epar-product-information_ro.pdf)

slovenčina (SK) (369.33 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/sk/documents/product-information/yttriga-epar-product-information_sk.pdf)

slovenščina (SL) (403.82 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/sl/documents/product-information/yttriga-epar-product-information_sl.pdf)

Suomi (FI) (358.13 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/fi/documents/product-information/yttriga-epar-product-information_fi.pdf)

svenska (SV) (309.2 KB - PDF)

**First published:**

19/08/2009

**Last updated:**

29/01/2021

[View](/sv/documents/product-information/yttriga-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0018 18/12/2020

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Yttriga : EPAR - All Authorised presentations

English (EN) (14.86 KB - PDF)

**First published:** 30/10/2006

**Last updated:** 11/02/2019

[View](/en/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-17)

български (BG) (79.42 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/bg/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_bg.pdf)

español (ES) (14.71 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/es/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_es.pdf)

čeština (CS) (81.17 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/cs/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (14.81 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/da/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (14.76 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/de/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (14.74 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/et/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (73.47 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/el/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_el.pdf)

français (FR) (14.83 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/fr/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (124.98 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/hr/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (14.75 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/is/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_is.pdf)

italiano (IT) (14.27 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/it/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (79.72 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/lv/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (78.4 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/lt/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (44.45 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/hu/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (81.23 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/mt/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (14.34 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/nl/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (14.76 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/no/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_no.pdf)

polski (PL) (83.29 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/pl/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_pl.pdf)

português (PT) (14.83 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/pt/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_pt.pdf)

română (RO) (79.14 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/ro/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (81.37 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/sk/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (50.87 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/sl/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (14.74 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/fi/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (14.81 KB - PDF)

**First published:**

30/10/2006

**Last updated:**

11/02/2019

[View](/sv/documents/all-authorised-presentations/yttriga-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Yttriga Active substance yttrium (90Y) chloride International non-proprietary name (INN) or common name yttrium [90Y] chloride Therapeutic area (MeSH) Radionuclide Imaging Anatomical therapeutic chemical (ATC) code V09

### Pharmacotherapeutic group

Diagnostic radiopharmaceuticals

### Therapeutic indication

To be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.

## Authorisation details

EMA product number EMEA/H/C/000596 Marketing authorisation holder

Eckert  Ziegler Radiopharma GmbH

Robert-Rossle-Str. 10 D-13125 Berlin Germany

Opinion adopted 15/09/2005 Marketing authorisation issued 19/01/2006 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Yttriga : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (169.7 KB - PDF)

**First published:** 19/08/2009

**Last updated:** 29/01/2021

[View](/en/documents/procedural-steps-after/yttriga-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Yttriga : EPAR - Scientific Discussion

English (EN) (277.5 KB - PDF)

**First published:** 30/10/2006

**Last updated:** 30/10/2006

[View](/en/documents/scientific-discussion/yttriga-epar-scientific-discussion_en.pdf)

Yttriga : EPAR - Procedural steps taken before authorisation

English (EN) (82.04 KB - PDF)

**First published:** 30/10/2006

**Last updated:** 30/10/2006

[View](/en/documents/procedural-steps/yttriga-epar-procedural-steps-taken-authorisation_en.pdf)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 29/01/2021

## Share this page

[Back to top](#main-content)